Search hospitals > New York > Rochester
University of Rochester
Claim this profileRochester, New York 14618
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for Lung Cancer
Conducts research for Recurrence
1134 reported clinical trials
65 medical researchers
Summary
University of Rochester is a medical facility located in Rochester, New York. This center is recognized for care of Cancer, Leukemia, Lymphoma, Lung Cancer, Recurrence and other specialties. University of Rochester is involved with conducting 1,134 clinical trials across 1,223 conditions. There are 65 research doctors associated with this hospital, such as Paul M. Barr, Yuhchyau Chen, Angela R. Girvin, and Craig A. Mullen.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Leukemia
Global LeaderStage II
Philadelphia chromosome positive
Stage I
Top PIs
Paul M. BarrUniversity of Rochester5 years of reported clinical research
Expert in Cancer
Expert in Lymphoma
74 reported clinical trials
147 drugs studied
Yuhchyau ChenUniversity of Rochester2 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
36 reported clinical trials
79 drugs studied
Angela R. GirvinUniversity of Rochester7 years of reported clinical research
Expert in Tumors
Expert in Neuroblastoma
30 reported clinical trials
70 drugs studied
Craig A. MullenUniversity of Rochester7 years of reported clinical research
Expert in Lymphoma
Expert in Brain Tumor
22 reported clinical trials
52 drugs studied
Clinical Trials running at University of Rochester
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Pancreatic Cancer
Multiple Myeloma
Lymphoma
Squamous Cell Carcinoma
Renal Cell Carcinoma
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Rochester?
University of Rochester is a medical facility located in Rochester, New York. This center is recognized for care of Cancer, Leukemia, Lymphoma, Lung Cancer, Recurrence and other specialties. University of Rochester is involved with conducting 1,134 clinical trials across 1,223 conditions. There are 65 research doctors associated with this hospital, such as Paul M. Barr, Yuhchyau Chen, Angela R. Girvin, and Craig A. Mullen.
Where is University of Rochester located?
The University of Rochester Medical Center is located at 601 Elmwood Ave, Rochester, NY 14620, on its campus. Multiple parking options are available, including a six-floor ramp garage connected to Strong Memorial Hospital, Golisano Children’s Hospital, and Wilmot Cancer Center.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Rochester Medical Center, including Strong Memorial Hospital and Highland Hospital:
- Contact the Financial Assistance Officer at (585) 784-8889 or (800) 257-7049 for insurance verification, Medicaid assistance, community outreach, financial counseling, and case management.
- To apply, submit an application with four consecutive paystubs, Social Security income, pension information, unemployment or workers' compensation award letters, or other proof of household gross income to: Financial Assistance Officer, Strong Memorial Hospital, 601 Elmwood Avenue – Box 888, Rochester, NY 14642.
- For more details, visit Highland Hospital's financial assistance page or Strong Memorial Hospital's financial assistance page for guidelines and FAQs.
What insurance does University of Rochester accept?
The University of Rochester accepts a wide range of insurance plans, including but not limited to Aetna, Beacon Health Options, CIGNA, Excellus BlueCross and BlueShield, Fidelis Care, Humana, MVP Health Care, TRICARE, UnitedHealthcare, and Wellcare by Fidelis Care Medicare Plans. UR Medicine also contracts with most major health insurance carriers. Patients are advised to contact their insurance company to confirm access to health care services at UR Medicine locations.
What awards or recognition has University of Rochester received?
The University of Rochester Medical Center (URMC) is a leading institution in biomedical research, receiving over $1.3 billion in funding over the past five years. The UR CTSI offers seed funding for innovative clinical and translational research projects, with grants from $10,000 to $200,000. This initiative supports researchers at all career stages, promoting the advancement of medical science and the improvement of human health.